The quality of life in implantable cardioverter defibrillator patients

Insights

Implantable cardioverter defibrillator (ICD) shocks negatively impact general health in patients. Patients receiving ICD shocks reported worse quality of life compared to those without shocks.

Area of Science:

  • Cardiology
  • Medical Devices
  • Patient Outcomes

Background:

  • Implantable cardioverter defibrillators (ICDs) reduce mortality in sudden cardiac death (SCD) patients.
  • ICDs can negatively affect psychological status and quality of life (QOL), particularly after receiving shocks.
  • This study investigated the impact of ICD shocks on patient QOL.

Purpose of the Study:

  • To compare the quality of life (QOL) between patients who received an implantable cardioverter defibrillator (ICD) shock and those who did not.
  • To assess the impact of ICD shocks on general health and mental well-being.

Main Methods:

  • Prospective study enrolling 138 patients with ICDs at a device clinic.
  • Quality of life assessed using the Medical Outcomes Study Short Form-36 Questionnaire (SF-36).
  • Comparison of QOL scores between patients who received ICD shocks and those who did not.

Main Results:

  • 48.55% of patients (67 out of 138) received at least one ICD shock.
  • Patients experiencing ICD shocks reported significantly worse general health compared to those without shocks (p=0.011).
  • No significant difference in mental health was observed between the shock and no-shock groups (p=0.63).

Conclusions:

  • ICD shocks significantly impair general health in patients.
  • While mental health was not significantly different, the impact on general health warrants attention.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
1.7K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
626